NCT02061280View on ClinicalTrials.gov

Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 17, 2017

Study Completion Date

February 17, 2017

Conditions
Asthma
Interventions
DRUG

fluticasone/salmeterol 250/50 Dry Powder Inhaler

Participants will receive Advair Diskus 250/50 Dry Powder Inhaler, administered twice daily for 12 weeks after randomization

DRUG

fluticasone/salmeterol 100/50 Dry Powder Inhaler

Participants will receive Advair Diskus 100/50 Dry Powder Inhaler administered twice daily for 12 weeks after randomization

DRUG

fluticasone 100mcg Dry Powder Inhaler

Participants will receive Flovent Diskus 100mcg Dry Powder Inhaler administered twice daily for 12 weeks after randomization

Trial Locations (5)

19803

Alfred I. duPont Hospital for Children, Wilmington

32207

Nemours Children's Specialty Care, Jacksonville

32504

Nemours Children's Specialty Care, Pensacola

32806

Nemours Children's Hospital, Orlando

63130

Washington University in St. Louis, St Louis

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Nemours Children's Clinic

OTHER

NCT02061280 - Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial | Biotech Hunter | Biotech Hunter